KS-20226

N/A

Report date: 2024/07/31 15:37:54
NME

Base Information

Drug NameKS-20226
Drug Alias NameKS20226KS-20226
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIron Responsive Element Binding Protein 2 inhibitors
TargetsIron Responsive Element Binding Protein 2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYonsei University
China Registration ClassN/A

Develop Information

Active CompaniesYonsei University
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A